Anixa Biosciences (ANIX) EBT Margin (QoQ) (2010 - 2018)
Anixa Biosciences (ANIX) EBT Margin (QoQ) (2010 - 2018) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 140.52 Bn | 132.67 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.54 Bn | 78.55 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.31 Bn | 60.13 Bn | 1.37 Bn |
| 4 | Moderna | 61.77 Bn | 56.64 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.26 Bn | 37.16 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.19 Bn | 27.88 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.71 Bn | 10.31 Bn | 668.28 Mn |
| 8 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.35 Bn | 26.52 Bn | - |
| 10 | Anixa Biosciences | 123.62 Mn | 123.62 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jul 31, 2018 | -135,739.00 |
| Oct 31, 2016 | 57,994.00 |
| Jul 31, 2015 | 726,018.00 |
| Apr 30, 2015 | -898,776.00 |
| Jan 31, 2015 | 27,042.00 |
| Oct 31, 2014 | -26,396.00 |
| Oct 31, 2012 | -53.13 Mn |
| Jul 31, 2012 | 10,140.00 |
| Apr 30, 2012 | -15,631.00 |
| Jan 31, 2012 | 42,448.00 |
| Oct 31, 2011 | -36,118.00 |
| Jul 31, 2011 | 122,023.00 |
| Apr 30, 2011 | 751,854.00 |
| Jan 31, 2011 | -863,728.00 |
| Oct 31, 2010 | 182,669.00 |